Tuesday, August 22, 2017 6:40:21 PM
OMHE will dilute, take on more debt, or issue more common stock to raise cash. They've already restructured the shares by converting common and paying insider preferred shares; which hardly benefits common shareholders at all, but ginormous gains can be had by the insiders who received the preferred shareholders.
There are no other alternatives if OMHE actually wants to purchase an MJ License in FL and actually cultivate/produce/sell marijuana.
IMO, they are merely baiting anything MJ to get people the perception that they're going to grow from the current single pharmacy retail store that they have been doing for 40+ years with underperforming results.
The business model being used is exactly like MCIG's. Bait with promises of streets paved with marijuana for 2-3 years, never execute, pay insiders as much as they can get away with....and actually produce nothing....
About a year later, and shareholders own a single pharmacy store in Hialeah, FL.....and a faux research lab - that will UNLIKELY EVER COME UP WITH ANY NEW PHARMACEUTICAL PRESCRIPTION MEDICATION APPROVED BY THE FDA.
IMO, they don't need $6 million to fund cosmetics where the company will merely add drops of CBD to Le Scam or CelebCream. the $6 mil is funding the insiders.....that's it.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM